SCHEMBL21600954

SCHEMBL21600954

C=CC(=O)Nc1cc(N2CCN(C)CC2)ccc1Nc1cc(NCc2cccnc2)c(C#N)cn1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 13/20 0.54
▸ HTR6 P50406 2/20 0.49
▸ HTR2A P28223 1/20 0.49
▸ JAK2 O60674 3/20 0.48
▸ JAK1 P23458 3/20 0.46
▸ EGFR P00533 1/20 0.45
▸ TTK P33981 1/20 0.45
▸ FLT3 P36888 1/20 0.45
▸ TXK P42681 1/20 0.45
▸ BLK P51451 1/20 0.45
▸ BTK Q06187 1/20 0.45
▸ ITK Q08881 1/20 0.45
▸ CTSC P53634 1/20 0.45
▸ FGFR1 P11362 2/20 0.44
▸ MAPT P10636 1/20 0.43
▸ FGFR2 P21802 1/20 0.43
▸ TYK2 P29597 1/20 0.43
▸ MAP3K7 O43318 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600898 0.93 FGFR4 (0.47) JAK3HTR6HTR2AJAK2EGFR
SCHEMBL21601014 0.89 JAK3 (0.52) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21600964 0.88 JAK3 (0.60) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21600973 0.87 JAK3 (0.55) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21600970 0.87 JAK3 (0.55) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21601024 0.86 JAK3 (0.51) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21600899 0.85 FGFR1 (0.49) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21601025 0.85 FGFR4 (0.51) JAK3JAK2JAK1FGFR1FGFR2
SCHEMBL21600955 0.83 JAK3 (0.47) JAK3HTR6HTR2AJAK2JAK1
SCHEMBL21600974 0.83 CTSC (0.52) JAK3JAK2EGFRFLT3BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242689-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2019-12-26 — — WO disclosed
Send feedback